Annual ROE
-81.47%
-17.50%-27.36%
December 31, 2023
Summary
- As of February 26, 2025, OBIO annual return on equity is -81.47%, with the most recent change of -17.50% (-27.36%) on December 31, 2023.
- During the last 3 years, OBIO annual ROE has fallen by -125.46% (-285.20%).
- OBIO annual ROE is now -285.20% below its all-time high of 43.99%, reached on December 31, 2020.
Performance
OBIO ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-97.70%
-15.60%-19.00%
September 30, 2024
Summary
- As of February 26, 2025, OBIO quarterly return on equity is -97.70%, with the most recent change of -15.60% (-19.00%) on September 30, 2024.
- Over the past year, OBIO quarterly ROE has increased by +4.66% (+4.55%).
- OBIO quarterly ROE is now -163.82% below its all-time high of 153.09%, reached on December 31, 2022.
Performance
OBIO Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
OBIO ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -27.4% | +4.5% |
| 3 y3 years | -285.2% | -163.8% |
| 5 y5 years | -285.2% | -163.8% |
OBIO ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -352.1% | at low | -163.8% | +66.4% |
| 5 y | 5-year | -285.2% | at low | -163.8% | +66.4% |
| alltime | all time | -285.2% | at low | -163.8% | +66.4% |
Orchestra BioMed Holdings ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -97.70%(+19.0%) |
| Jun 2024 | - | -82.10%(+25.3%) |
| Mar 2024 | - | -65.52%(+3.9%) |
| Dec 2023 | -81.47% | -63.07%(-38.4%) |
| Sep 2023 | - | -102.36%(-64.8%) |
| Jun 2023 | - | -290.45%(+39.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | -208.52%(-236.2%) |
| Dec 2022 | -63.97%(-298.0%) | 153.09%(+437.9%) |
| Sep 2022 | - | 28.46%(+75.8%) |
| Jun 2022 | - | 16.19%(+101.4%) |
| Mar 2022 | - | 8.04% |
| Dec 2021 | 32.31%(-26.6%) | - |
| Dec 2020 | 43.99% | - |
FAQ
- What is Orchestra BioMed Holdings annual return on equity?
- What is the all time high annual ROE for Orchestra BioMed Holdings?
- What is Orchestra BioMed Holdings annual ROE year-on-year change?
- What is Orchestra BioMed Holdings quarterly return on equity?
- What is the all time high quarterly ROE for Orchestra BioMed Holdings?
- What is Orchestra BioMed Holdings quarterly ROE year-on-year change?
What is Orchestra BioMed Holdings annual return on equity?
The current annual ROE of OBIO is -81.47%
What is the all time high annual ROE for Orchestra BioMed Holdings?
Orchestra BioMed Holdings all-time high annual return on equity is 43.99%
What is Orchestra BioMed Holdings annual ROE year-on-year change?
Over the past year, OBIO annual return on equity has changed by -17.50% (-27.36%)
What is Orchestra BioMed Holdings quarterly return on equity?
The current quarterly ROE of OBIO is -97.70%
What is the all time high quarterly ROE for Orchestra BioMed Holdings?
Orchestra BioMed Holdings all-time high quarterly return on equity is 153.09%
What is Orchestra BioMed Holdings quarterly ROE year-on-year change?
Over the past year, OBIO quarterly return on equity has changed by +4.66% (+4.55%)